Home » Authors » James Etheridge

Articles by James Etheridge

Innogenetics Plans To Raise EUR39M Through Public Offering

Dec. 3, 2003

By James Etheridge

As Part Of Deal, ExonHit Delivers Small-Molecule Target to Allergan

Nov. 26, 2003

By James Etheridge

As Part Of Deal, ExonHit Delivers Small-Molecule Target to Allergan

Nov. 26, 2003

By James Etheridge

Cellectis Signs Fermentas To Manufacturing Deal For I-Sce1

Nov. 19, 2003

By James Etheridge

Cellectis Signs Fermentas To Manufacturing Deal For I-Sce1

Nov. 19, 2003

By James Etheridge

GSK To Terminate Augmentin Formulation Deal With Flamel

Oct. 29, 2003

By James Etheridge

GSK To Terminate Augmentin Formulation Deal With Flamel

Oct. 29, 2003

By James Etheridge

IDM To Coordinate European Project For Cancer Vaccine

Oct. 22, 2003

By James Etheridge

BioProtein Adds Recombinant Vaccines To Product Offerings

Oct. 22, 2003

By James Etheridge

BioProtein Adds Recombinant Vaccines To Product Offerings

Oct. 22, 2003

By James Etheridge

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...